158 related articles for article (PubMed ID: 36092961)
1. PIAS1 Alleviates Hepatic Ischemia-Reperfusion Injury in Mice through a Mechanism Involving NFATc1 SUMOylation.
Luo J; Li J; Li T; Zhang Z; Chen G; Li Q; Qi H; Si Z
Dis Markers; 2022; 2022():4988539. PubMed ID: 36092961
[TBL] [Abstract][Full Text] [Related]
2. PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation.
Xie B; Liu X; Yang J; Cheng J; Gu J; Xue S
BMC Cell Biol; 2018 Nov; 19(1):24. PubMed ID: 30419807
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity.
Heo KS; Chang E; Takei Y; Le NT; Woo CH; Sullivan MA; Morrell C; Fujiwara K; Abe J
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):321-9. PubMed ID: 23202365
[TBL] [Abstract][Full Text] [Related]
4. A role for protein inhibitor of activated STAT1 (PIAS1) in lipogenic regulation through SUMOylation-independent suppression of liver X receptors.
Zhang Y; Gan Z; Huang P; Zhou L; Mao T; Shao M; Jiang X; Chen Y; Ying H; Cao M; Li J; Li J; Zhang WJ; Yang L; Liu Y
J Biol Chem; 2012 Nov; 287(45):37973-85. PubMed ID: 22969086
[TBL] [Abstract][Full Text] [Related]
5. CDKN2A deregulation in fatty liver disease and its accelerative role in the process of lipogenesis.
Zhang Z; Wen H; Peng B; Weng J; Zeng F
FASEB J; 2021 Apr; 35(4):e21230. PubMed ID: 33769609
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cysteine-serine-rich nuclear protein 1 ameliorates ischemia-reperfusion injury during liver transplantation in an MAPK-dependent manner.
Wang Z; Ge W; Zhong X; Tong S; Zheng S; Xu X; Wang K
Mol Biomed; 2024 Jun; 5(1):22. PubMed ID: 38902590
[TBL] [Abstract][Full Text] [Related]
7. Protein inhibitor of activated STAT1 Ser
Liu SY; Ma YL; Hsu WL; Chiou HY; Lee EHY
Br J Pharmacol; 2019 Jun; 176(11):1793-1810. PubMed ID: 30849179
[TBL] [Abstract][Full Text] [Related]
8. Mu-opioid receptor alleviated ferroptosis in hepatic ischemia-reperfusion injury via the HIF-1α/
Zou S; Sun H; Peng Y; Liang C; Zheng C; Wang L; Yang J
Am J Physiol Cell Physiol; 2023 Apr; 324(4):C927-C940. PubMed ID: 36717099
[TBL] [Abstract][Full Text] [Related]
9. Interferon regulatory factor-1 activates autophagy to aggravate hepatic ischemia-reperfusion injury via the P38/P62 pathway in mice.
Yu Y; Li S; Wang Z; He J; Ding Y; Zhang H; Yu W; Shi Y; Cui Z; Wang X; Wang Z; Sun L; Zhang R; Du H; Zhu Z
Sci Rep; 2017 Mar; 7():43684. PubMed ID: 28266555
[TBL] [Abstract][Full Text] [Related]
10. CXCL16 silencing alleviates hepatic ischemia reperfusion injury during liver transplantation by inhibiting p38 phosphorylation.
Zhang Y; Pan Q; Liu Y
Pathol Res Pract; 2020 May; 216(5):152913. PubMed ID: 32171552
[TBL] [Abstract][Full Text] [Related]
11. Oxidative and ER stress-dependent ASK1 activation in steatotic hepatocytes and Kupffer cells sensitizes mice fatty liver to ischemia/reperfusion injury.
Imarisio C; Alchera E; Bangalore Revanna C; Valente G; Follenzi A; Trisolini E; Boldorini R; Carini R
Free Radic Biol Med; 2017 Nov; 112():141-148. PubMed ID: 28739531
[TBL] [Abstract][Full Text] [Related]
12. The effect of Ginsenoside Rg1 in hepatic ischemia reperfusion (I/R) injury ameliorates ischemia-reperfusion-induced liver injury by inhibiting apoptosis.
Lin J; Huang HF; Yang SK; Duan J; Qu SM; Yuan B; Zeng Z
Biomed Pharmacother; 2020 Sep; 129():110398. PubMed ID: 32603889
[TBL] [Abstract][Full Text] [Related]
13. Protein inhibitor of activated STAT-1 is downregulated in gastric cancer tissue and involved in cell metastasis.
Chen P; Zhao D; Sun Y; Huang L; Zhang S; Yuan Y
Oncol Rep; 2012 Dec; 28(6):2149-55. PubMed ID: 22972521
[TBL] [Abstract][Full Text] [Related]
14. Sumoylation of a small isoform of NFATc1 is promoted by PIAS proteins and inhibits transactivation activity.
Kim ET; Kwon KM; Lee MK; Park J; Ahn JH
Biochem Biophys Res Commun; 2019 May; 513(1):172-178. PubMed ID: 30952432
[TBL] [Abstract][Full Text] [Related]
15. Novel role and mechanism of protein inhibitor of activated STAT1 in spatial learning.
Tai DJ; Hsu WL; Liu YC; Ma YL; Lee EH
EMBO J; 2011 Jan; 30(1):205-20. PubMed ID: 21102409
[TBL] [Abstract][Full Text] [Related]
16. PIAS1-mediated SUMOylation of influenza A virus PB2 restricts viral replication and virulence.
Wang G; Zhao Y; Zhou Y; Jiang L; Liang L; Kong F; Yan Y; Wang X; Wang Y; Wen X; Zeng X; Tian G; Deng G; Shi J; Liu L; Chen H; Li C
PLoS Pathog; 2022 Apr; 18(4):e1010446. PubMed ID: 35377920
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of HDAC1 SUMOylation as an endogenous neuroprotection against Aβ toxicity in a mouse model of Alzheimer's disease.
Tao CC; Hsu WL; Ma YL; Cheng SJ; Lee EH
Cell Death Differ; 2017 Apr; 24(4):597-614. PubMed ID: 28186506
[TBL] [Abstract][Full Text] [Related]
18.
Su S; Luo D; Liu X; Liu J; Peng F; Fang C; Li B
Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28842516
[TBL] [Abstract][Full Text] [Related]
19. SUMO Ligase Protein Inhibitor of Activated STAT1 (PIAS1) Is a Constituent Promyelocytic Leukemia Nuclear Body Protein That Contributes to the Intrinsic Antiviral Immune Response to Herpes Simplex Virus 1.
Brown JR; Conn KL; Wasson P; Charman M; Tong L; Grant K; McFarlane S; Boutell C
J Virol; 2016 Jul; 90(13):5939-5952. PubMed ID: 27099310
[TBL] [Abstract][Full Text] [Related]
20. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
